Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IN8BIO, INC. Director's Dealing 2021

Nov 23, 2021

35200_dirs_2021-11-23_d2e1d1bd-be5f-4d1d-9800-638f26628ba5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2021-11-19

Reporting Person: Goswami Trishna (Chief Medical Officer)